These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 28865379)
21. Tolerability, Safety, and Effectiveness of Oxycodone DETERx in Elderly Patients ≥65 Years of Age with Chronic Low Back Pain: A Randomized Controlled Trial. Kopecky EA; Vaughn B; Lagasse S; O'Connor M Drugs Aging; 2017 Aug; 34(8):603-613. PubMed ID: 28600725 [TBL] [Abstract][Full Text] [Related]
22. The genetic influences on oxycodone response characteristics in human experimental pain. Olesen AE; Sato H; Nielsen LM; Staahl C; Droney J; Gretton S; Branford R; Drewes AM; Arendt-Nielsen L; Riley J; Ross J Fundam Clin Pharmacol; 2015 Aug; 29(4):417-25. PubMed ID: 26042474 [TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of oxymorphone extended release in chronic low back pain: results of a randomized, double-blind, placebo- and active-controlled phase III study. Hale ME; Dvergsten C; Gimbel J J Pain; 2005 Jan; 6(1):21-8. PubMed ID: 15629415 [TBL] [Abstract][Full Text] [Related]
24. Differential effect of opioids in patients with chronic pancreatitis: an experimental pain study. Staahl C; Dimcevski G; Andersen SD; Thorsgaard N; Christrup LL; Arendt-Nielsen L; Drewes AM Scand J Gastroenterol; 2007 Mar; 42(3):383-90. PubMed ID: 17354119 [TBL] [Abstract][Full Text] [Related]
25. Pain relief and tolerability balance of immediate release tapentadol or oxycodone treatment for patients with moderate to severe osteoarthritis or low back pain. Kavanagh S; Kwong WJ; Hammond GC; Nelson W; Upmalis D; Yang M Pain Med; 2012 Sep; 13(9):1110-20. PubMed ID: 22845494 [TBL] [Abstract][Full Text] [Related]
26. Opioid agonist efficacy predicts the magnitude of tolerance and the regulation of mu-opioid receptors and dynamin-2. Pawar M; Kumar P; Sunkaraneni S; Sirohi S; Walker EA; Yoburn BC Eur J Pharmacol; 2007 Jun; 563(1-3):92-101. PubMed ID: 17349996 [TBL] [Abstract][Full Text] [Related]
27. Analgesic effect of clobazam in chronic low-back pain but not in experimentally induced pain. Schliessbach J; Vuilleumier PH; Siegenthaler A; Bütikofer L; Limacher A; Juni P; Zeilhofer HU; Arendt-Nielsen L; Curatolo M Eur J Pain; 2017 Sep; 21(8):1336-1345. PubMed ID: 28418172 [TBL] [Abstract][Full Text] [Related]
28. Differential alternation of the antinociceptive effect of narcotic analgesics on the inflammatory pain state. Aoki Y; Mizoguchi H; Watanabe C; Sakurada T; Sakurada S Neurosci Lett; 2014 Feb; 560():122-5. PubMed ID: 24361775 [TBL] [Abstract][Full Text] [Related]
29. Association between a composite score of pain sensitivity and clinical parameters in low-back pain. O'Neill S; Manniche C; Graven-Nielsen T; Arendt-Nielsen L Clin J Pain; 2014 Oct; 30(10):831-8. PubMed ID: 24121529 [TBL] [Abstract][Full Text] [Related]
30. Tapentadol immediate release versus oxycodone immediate release for treatment of acute low back pain. Biondi D; Xiang J; Benson C; Etropolski M; Moskovitz B; Rauschkolb C Pain Physician; 2013; 16(3):E237-46. PubMed ID: 23703422 [TBL] [Abstract][Full Text] [Related]
32. A comparative study of oxycodone and morphine in a multi-modal, tissue-differentiated experimental pain model. Staahl C; Christrup LL; Andersen SD; Arendt-Nielsen L; Drewes AM Pain; 2006 Jul; 123(1-2):28-36. PubMed ID: 16600508 [TBL] [Abstract][Full Text] [Related]
33. Activation of delta-opioid receptor contributes to the antinociceptive effect of oxycodone in mice. Yang PP; Yeh GC; Yeh TK; Xi J; Loh HH; Law PY; Tao PL Pharmacol Res; 2016 Sep; 111():867-876. PubMed ID: 27496654 [TBL] [Abstract][Full Text] [Related]
34. Efficacy of tapentadol ER for managing moderate to severe chronic pain. Afilalo M; Morlion B Pain Physician; 2013 Jan; 16(1):27-40. PubMed ID: 23340531 [TBL] [Abstract][Full Text] [Related]
35. Dissociation of rewarding, anti-aversive and anti-nociceptive effects of different classes of anti-nociceptives in the rat. Rutten K; De Vry J; Robens A; Tzschentke TM; van der Kam EL Eur J Pain; 2011 Mar; 15(3):299-305. PubMed ID: 20801699 [TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetic and pharmacodynamic evaluation of oxycodone and naltrexone for the treatment of chronic lower back pain. Davis MP Expert Opin Drug Metab Toxicol; 2016 Jul; 12(7):823-31. PubMed ID: 27253690 [TBL] [Abstract][Full Text] [Related]